About 4D Medicine
4D Medicine is a company based in Birmingham (United Kingdom) founded in 2018 by Andrew Dove. 4D Medicine has raised $6.6 million across 2 funding rounds from investors including DSW Ventures, SFC Capital and Boundary Capital Partners. 4D Medicine offers products and services including 4Degra® and Bioabsorbable Interference Screw. 4D Medicine operates in a competitive market with competitors including CELLINK, Checkerspot, OxSyBio, Collplant and Fermbox, among others.
- Headquarter Birmingham, United Kingdom
- Founders Andrew Dove
-
Sectors
HealthcareTechnology Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 4D Biomaterials Ltd
- Date of Incorporation 12 Jul, 2023
- Jurisdiction NOTTINGHAM, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.6 M (USD)
in 2 rounds
-
Latest Funding Round
$4.39 M (USD), Series A
Jul 25, 2024
-
Investors
DSW Ventures
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 4D Medicine
4D Medicine offers a comprehensive portfolio of products and services, including 4Degra® and Bioabsorbable Interference Screw.
Patented polymer for bioabsorbable medical devices.
Device for surgical fixation using biodegradable materials.
Funding Insights of 4D Medicine
4D Medicine has successfully raised a total of $6.6M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.39 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 4D Medicine
4D Medicine has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include DSW Ventures, SFC Capital and Boundary Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in early-stage UK regional startups.
|
Locked | Locked | Locked | |
|
Introductions between investors and early-stage companies are facilitated for funding.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for 4D Medicine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 4D Medicine
Investment portfolio details for 4D Medicine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 4D Medicine
Detailed financials for 4D Medicine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
4D Medicine Comparisons
Peer comparison for 4D Medicine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 4D Medicine
4D Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CELLINK, Checkerspot, OxSyBio, Collplant and Fermbox, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
3D bioprinters and bioinks are developed for research applications.
|
|
| Locked | Locked | Locked |
High-performance materials are developed using synthetic biology for diverse applications.
|
|
| Locked | Locked | Locked |
Provider of 3D printing of tissue biomaterials for medical research and clinical applications
|
|
| Locked | Locked | Locked |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| Locked | Locked | Locked |
Alternative animal products are developed via microbial precision fermentation.
|
|
| Locked | Locked | Locked |
3D tissue engineering technology is developed for regenerative medicine applications.
|
Detailed competitors of 4D Medicine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 4D Medicine
Complete news archive for 4D Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 4D Medicine
4D Medicine was founded in 2018 and raised its 1st funding round 3 years after it was founded.
4D Medicine is headquartered in Birmingham, United Kingdom. It is registered at Birmingham, England, United Kingdom.
Phil Smith is the current CEO of 4D Medicine.
4D Medicine is a funded company, having raised a total of $6.6M across 2 funding rounds to date.
4D Medicine was established in 2018 in Birmingham, United Kingdom, within the biotechnology sector. Transformative gene therapies targeting serious unmet medical needs are researched, developed, and commercialized. Operations extend to two subsidiaries focused on advancing non-invasive, quantitative lung function imaging and analysis technologies. Activities emphasize clinical applications for respiratory diagnostics and therapeutic innovations in the healthcare domain.
4D Medicine's top competitors include Checkerspot, Cyfuse and Collplant.
4D Medicine offers 4Degra® and Bioabsorbable Interference Screw.
4D Medicine has 6 investors. Key investors include DSW Ventures, SFC Capital, Boundary Capital Partners, Oshen, and Midlands Engine Investment Fund.